It has also
been observed that CIA mice treated with blocking anti-ST2 antibody,
initiated at the onset of arthritis, slightly delayed evolution
of the disease [12]. The evolution of clinical severity scores was
markedly decreased and the numbers of affected paws tended to
be lower in the anti-ST2 antibody-treated mice [12].